Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Patients with systemic lupus erythematosus (SLE) who test positive for antiphospholipid antibodies (aPLs) are at a significantly higher risk of developing diffuse alveolar hemorrhage (DAH), according ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Disease-modifying therapy use for MS in pregnancy is associated with certain adverse outcomes, including small for gestational age.

There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD).

COVID-19 infection is associated with accelerated decline in kidney function, especially after hospitalization.

Severe maternal morbidity events in first pregnancy were associated with a significantly reduced likelihood of subsequent delivery.

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

A recent study finds that the prevalence of post-COVID-19 condition was 8.4 percent among U.S. adults in 2023.

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes.

Alcohol consumption was associated with lower levels of axSpA disease activity and spinal pain, but may be linked to ...

For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes compared with tofacitinib.